Aging Research Center & Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
PLoS Med. 2020 Dec 15;17(12):e1003474. doi: 10.1371/journal.pmed.1003474. eCollection 2020 Dec.
BACKGROUND: Very few studies have explored the patterns of cardiovascular health (CVH) metrics in midlife and late life in relation to risk of dementia. We examined the associations of composite CVH metrics from midlife to late life with risk of incident dementia. METHODS AND FINDINGS: This cohort study included 1,449 participants from the Finnish Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) study, who were followed from midlife (baseline from1972 to 1987; mean age 50.4 years; 62.1% female) to late life (1998), and then 744 dementia-free survivors were followed further into late life (2005 to 2008). We defined and scored global CVH metrics based on 6 of the 7 components (i.e., smoking, physical activity, and body mass index [BMI] as behavioral CVH metrics; fasting plasma glucose, total cholesterol, and blood pressure as biological CVH metrics) following the modified American Heart Association (AHA)'s recommendations. Then, the composite global, behavioral, and biological CVH metrics were categorized into poor, intermediate, and ideal levels. Dementia was diagnosed following the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. Data were analyzed with Cox proportional hazards and the Fine and Gray competing risk regression models. During the follow-up examinations, dementia was diagnosed in 61 persons in 1998 and additional 47 persons in 2005 to 2008. The fully adjusted hazard ratio (HR) of dementia was 0.71 (95% confidence interval [CI]: 0.43, 1.16; p = 0.174) and 0.52 (0.29, 0.93; p = 0.027) for midlife intermediate and ideal levels (versus poor level) of global CVH metrics, respectively; the corresponding figures for late-life global CVH metrics were 0.60 (0.22, 1.69; p = 0.338) and 0.91 (0.34, 2.41; p = 0.850). Compared with poor global CVH metrics in both midlife and late life, the fully adjusted HR of dementia was 0.25 (95% CI: 0.08, 0.86; p = 0.028) for people with intermediate global CVH metrics in both midlife and late life and 0.14 (0.02, 0.76; p = 0.024) for those with midlife ideal and late-life intermediate global CVH metrics. Having an intermediate or ideal level of behavioral CVH in both midlife and late life (versus poor level in both midlife and late life) was significantly associated with a lower dementia risk (HR range: 0.03 to 0.26; p < 0.05), whereas people with midlife intermediate and late-life ideal biological CVH metrics had a significantly increased risk of dementia (p = 0.031). Major limitations of this study include the lack of data on diet and midlife plasma glucose, high rate of attrition, as well as the limited power for certain subgroup analyses. CONCLUSIONS: In this study, we observed that having the ideal CVH metrics, and ideal behavioral CVH metrics in particular, from midlife onwards is associated with a reduced risk of dementia as compared with people having poor CVH metrics. Maintaining life-long health behaviors may be crucial to reduce late-life risk of dementia.
背景:很少有研究探讨中年和晚年心血管健康(CVH)指标与痴呆风险之间的关系模式。我们研究了从中年到晚年的复合 CVH 指标与痴呆发病风险的相关性。
方法和发现:这项队列研究包括来自芬兰心血管风险因素、衰老和痴呆(CAIDE)研究的 1449 名参与者,他们从中年(从 1972 年到 1987 年;平均年龄 50.4 岁;62.1%为女性)开始随访,直到晚年(1998 年),然后进一步随访了 744 名无痴呆幸存者进入晚年(2005 年至 2008 年)。我们根据改良后的美国心脏协会(AHA)建议,基于 7 个成分中的 6 个(即吸烟、体力活动和身体质量指数[BMI]作为行为 CVH 指标;空腹血糖、总胆固醇和血压作为生物 CVH 指标)定义和评分全球 CVH 指标。然后,将复合全球、行为和生物 CVH 指标分为差、中、优水平。痴呆根据《精神障碍诊断与统计手册》第四版(DSM-IV)标准进行诊断。使用 Cox 比例风险和 Fine 和 Gray 竞争风险回归模型进行数据分析。在随访检查中,1998 年诊断出 61 人患有痴呆,2005 年至 2008 年又诊断出 47 人患有痴呆。全球 CVH 指标的中龄和理想水平(与差水平相比)的完全调整后的痴呆风险比(HR)分别为 0.71(95%置信区间[CI]:0.43,1.16;p=0.174)和 0.52(0.29,0.93;p=0.027);晚年全球 CVH 指标的相应数值分别为 0.60(0.22,1.69;p=0.338)和 0.91(0.34,2.41;p=0.850)。与中龄和晚年全球 CVH 指标都差的人相比,中龄和晚年全球 CVH 指标都为中或优的人,其完全调整后的痴呆风险 HR 为 0.25(95%CI:0.08,0.86;p=0.028);中龄理想、晚年为中龄 CVH 指标的人,其痴呆风险 HR 为 0.14(0.02,0.76;p=0.024)。中龄和晚年都有中或优的行为 CVH 水平(与中龄和晚年都差的水平相比)与痴呆风险降低显著相关(HR 范围:0.03 至 0.26;p<0.05),而中龄和晚年都有中或优的生物 CVH 指标的人患痴呆的风险显著增加(p=0.031)。这项研究的主要局限性包括缺乏关于饮食和中龄血糖的数据、高失访率以及某些亚组分析的有限能力。
结论:在这项研究中,我们观察到,与具有差 CVH 指标的人相比,从中年开始具有理想的 CVH 指标,特别是理想的行为 CVH 指标,与痴呆风险降低相关。保持终生健康行为可能对降低晚年痴呆风险至关重要。
Nutr Metab Cardiovasc Dis. 2018-12
Eur J Prev Cardiol. 2024-4-18
Alzheimers Dement. 2025-5
Alzheimers Res Ther. 2024-3-14
Int J Geriatr Psychiatry. 2019-12-6
BMC Med. 2019-3-20
J Am Heart Assoc. 2018-8-21
Alzheimers Dement. 2018-3-2
Alzheimers Dement. 2017-12-18